UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011765
Receipt number R000013757
Scientific Title Study of the clinical effects by the central supply method of the acetic acid-free dialytic fluid
Date of disclosure of the study information 2013/09/17
Last modified on 2013/09/14 12:55:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of the clinical effects by the central supply method of the acetic acid-free dialytic fluid

Acronym

clinical effects of the acetic acid-free dialytic fluid

Scientific Title

Study of the clinical effects by the central supply method of the acetic acid-free dialytic fluid

Scientific Title:Acronym

clinical effects of the acetic acid-free dialytic fluid

Region

Japan


Condition

Condition

end-stage renal failure

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In 2007, first acetic acid-free dialytic fluid (car placard) was released in a country. The car placard has a metabolic acidotic superior correction effect, and the dialysis that National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (K/DOQI) guideline "which the HCO3 density should maintain in blood before dialysis of the hemodialysis patient than 22 mEq/L" recommends is possible. We examine an effect to give a clinical response of acetic acid dialytic fluid and the acetic acid-free dialytic fluid in the central supply method and antioxidant ability.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

For a hemodialysis patient, we examine a 12-month clinical response of acetic acid-free dialytic fluid after use in acetic acid dialytic fluid for six months. Examination item are dialysis efficiency (Kt/V), a circulation change (mean blood pressure and the pulse), nourishment dialyzing are in a state (serum protein and albumin, nPCR), acidotic improvement effect (pH, HCO3-, BE).

Key secondary outcomes

For a hemodialysis patient, we measure a 12-month oxidation stress marker of acetic acid-free dialytic fluid after use in acetic acid dialytic fluid for six months. Examination item are blood reduced glutathione/oxidized glutathione ratio and serum MDA-LDL.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

six months of Acetic acid component dialytic fluid use, and then 12 months of acetic acid-free dialytic fluid use

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

end-stage renal failure patients with stable outpatient maintenance hemodialysis 20 years or older

Key exclusion criteria

hemodialysis patients without any cancer or acute Inflammation

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akira Tsuji

Organization

National Defense Medical College Hospital

Division name

Department of Blood Purification

Zip code


Address

3-2 Namiki, Tokorozawa Saitma, Japan

TEL

04-2995-1511

Email

futebol@ndmc.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kaori Ishizeki

Organization

National Defense Medical College Hospital

Division name

Department of Blood Purification

Zip code


Address

3-2 Namiki, Tokorozawa Saitma, Japan

TEL

04-2995-1511

Homepage URL


Email

halfmoon@ndmc.ac.jp


Sponsor or person

Institute

National Defense Medical College

Institute

Department

Personal name



Funding Source

Organization

Foundation for Promotion of Defense Medicine

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

防衛医科大学校病院(埼玉県) National Defense Medical College Hospital (Saitama)


Other administrative information

Date of disclosure of the study information

2013 Year 09 Month 17 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

58th Congress of the Japanese Society for Dialysis therapy

Acetic acid-free dialytic fluid accepted meaningful improvement of acidotic revision, a nourishment state and anemia. By the long usage of the acetic acid-free dialytic fluid, blood GSH/GSSG was improved significantly, and plasma homocysteine significantly decreased. Thus, an effect to prevent the serious complications in the chronic hemodialysis patient is expected.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 10 Month 21 Day

Date of IRB


Anticipated trial start date

2010 Year 11 Month 01 Day

Last follow-up date

2012 Year 06 Month 03 Day

Date of closure to data entry

2012 Year 07 Month 25 Day

Date trial data considered complete

2012 Year 08 Month 05 Day

Date analysis concluded

2012 Year 10 Month 04 Day


Other

Other related information



Management information

Registered date

2013 Year 09 Month 14 Day

Last modified on

2013 Year 09 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013757


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name